Eli Lilly Adds Warning Labels To Zyprexa

Law360, New York (October 9, 2007, 12:00 AM EDT) -- Drug maker Eli Lilly and Co. has decided to put stronger product labels on its blockbuster antipsychotic treatment Zyprexa, adding new warnings about the potential for weight gain and elevated blood sugar or cholesterol levels.

Zyprexa, the brand name version of olanzapine, is an atypical anti-psychotic prescription medication used to treat symptoms of various psychiatric conditions, including schizophrenia and bipolar disorder.

Lilly said the decision reflected both new analysis of clinical trial data and ongoing discussions with the U.S. Food and Drug Administration. The company also...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.